Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
"Forty-two-three domain containing 1 pseudogene" is a noncoding genomic sequence homologous to the protein-coding gene FYTTD1 (also known as UIF, UAP56-interacting factor)[2][4]. Pseudogenes typically arise from gene duplication or retrotransposition events and are generally nonfunctional due to disabling mutations. While most pseudogenes like this do not encode proteins, some may exert regulatory effects at the RNA level, impacting gene expression or acting as competing endogenous RNAs, though no such functionality is established for this pseudogene[3]. The parent gene, FYTTD1, is involved in mRNA export from the nucleus[7], but the pseudogene itself does not retain this function. There are no known drug interactions, therapeutic mechanisms, or established biomarker roles for this pseudogene. - The use of "forty-two-three domain containing 1 pseudogene" as a target is likely incorrect for therapeutic or research targeting purposes, as it is not an active receptor, enzyme, transporter, or signaling protein. - If a functional target is intended, the correct target should be "Forty-two-three domain containing 1" (FYTTD1, UIF), not the pseudogene variant[2][4][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Forty-two-three domain containing 1 pseudogene.